Impact of the donor liver with steatosis in patients with hepatitis C virus: Not so fAsT

Liver Transplantation

Volumn 15, Issue 1, 2009, Pages 4-6

  Yilmaz, Nevin ^a   Shiffman, Mitchell L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE;

AMINOTRANSFERASE BLOOD LEVEL; COLD ISCHEMIA; DISEASE COURSE; DONOR SELECTION; EDITORIAL; FATTY LIVER; GRAFT FAILURE; GRAFT SURVIVAL; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; ORGAN DONOR; PRIORITY JOURNAL; RECURRENT INFECTION; REPERFUSION INJURY; RISK FACTOR;

FATTY LIVER; FIBROSIS; GRAFT SURVIVAL; HEPACIVIRUS; HEPATITIS C; HUMANS; ISCHEMIA; LIVER TRANSPLANTATION; RECURRENCE; RISK FACTORS; TISSUE DONORS;

EID: 64049114116     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21661     Document Type: Editorial

References (27)

1. Ong JP, Younossi ZM. Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis 2007;11:1-16.
2. Boin IF, Kajikawa P, Palmiero HO, Zambelli H, Bello Stucchi R, Iracema Leonardi M, Sergio Leonardi L. Profile of cadaveric liver donors of the OPO-UNICAMP from 2002 to 2006. Transplant Proc 2008;40:657-659.
3. Hidden M, Christofferson P, Juhl E, Dalgaard JB. Liver histology in a 'normal' population - examination of 503 consecutive fatal traffic casualties. Scand J Gastroenterol 1997;12:593-597.
4. Markin RS, Wisecarver JL, Radio SJ, Stratta RJ, Langnas AN, Hirst K, Shaw BW Jr. Frozen section evaluation of donor livers before transplantation. Transplantation 1993;56:1403-1409.
5. Selzner M, Clavien PA. Fatty liver in liver transplantation and surgery. Semin Liver Dis 2001;21:105-113.
6. Imber CJ, St. Peter SD, Handa A, Friend PJ. Hepatic steatosis and its relationship to transplantation. Liver Transpl 2002;8:415-423.
7. Marcos A, Fisher RA, Ham JM, Olzinski AT, Shiffman ML, Sanyal AJ, et al. Selection and outcome of living donors for adult to adult right lobe transplantation. Transplantation 2000;69:2410-2415.
8. Soejima Y, Shimada M, Suehiro T, Kishikawa K, Yoshizumi T, Hashimoto K, et al. Use of steatotic graft in living-donor liver transplantation. Transplantation 2003;76:344-348.
9. Shiffman ML, Saab S, Feng S, Abecassis MI, Tzakis AG, Goodrich NP, Schaubel DE. Liver and intestine transplantation in the United States, 1995-2004. Am J Transplant 2006;6(suppl 2):1170-1187.
10. Brown RS Jr. Hepatitis C and liver transplantation. Nature 2005;436:973-978.
11. Yilmaz N, Shiffman ML, Stravitz RT, Sterling RK, Luketic VA, Sanyal AJ, et al. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation. Liver Transpl 2007;13:975-983.
12. Neumann UP, Berg T, Bahra M, Seehofer D, Langrehr JM, Neuhaus R, et al. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C. J Hepatol 2004;41:830-836.
13. Cameron AM, Ghobrial RM, Hiatt JR, Carmody IC, Gordon SA, Farmer DG, et al. Effect of nonviral factors on hepatitis C recurrence after liver transplantation. Ann Surg 2006; 244:563-571.
14. Machicao VI, Bonatti H, Krishna M, Aqel BA, Lukens FJ, Nguyen JH, et al. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation 2004;77:84-92.
15. Prieto M, Berenguer M, Rayon JM, Cordoba J, Arguello L, Carrasco D, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology 1999;29:250-256.
16. Chopra KB, Demetris AJ, Blakolmer K, Dvorchik I, Laskus T, Wang LF, et al. Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation. Transplantation 2003;76:1487-1491.
17. Shiffman ML, Vargus HE, Everson GT. Controversies in the management of hepatitis C virus infection after liver transplantation. Liver Transpl 2003;9:1129-1144.
18. Clouston AD, Jonsson JR, Powell EE. Steatosis as a cofactor in other liver diseases: hepatitis C virus, alcohol, hemochromatosis, and others. Clin Liver Dis 2007;11: 173-189.
19. Botha JF, Thompson E, Gilroy R, Grant WJ, Mukherjee S, Lyden ER, et al. Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation. Liver Int 2007;27:758-763.
20. McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Weber M, Clavien PA. Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg 2007;246:940-946.
21. Verran D, Dilworth P, Tang P, McCaughan G. Use of severely steatotic grafts in liver transplantation. Ann Surg 2008;248:142-143.
22. Machicao VI, Krishna M, Bonatti H, Aqel BA, Nguyen JH, Weigand SD, et al. Hepatitis C recurrence is not associated with allograft steatosis within the first year after liver transplantation. Liver Transpl 2004;10:599-606.
23. Brinceño J, Ciria R, Pleguezuelo M, Mata M, Muntane J, Naranjo A, et al. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis. Liver Transpl 2008;15:37-48.
24. Schluger LK, Sheiner PA, Thung SN, Lau JY, Min A, Wolf DC, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996;23: 971-976.
25. Dixon LR, Crawford JM. Early histologic changes in fibrosing cholestatic hepatitis C. Liver Transpl 2007;13:219-226.
26. Shiffman ML, Contos MJ, Fisher RA, Mills AS, Luketic VA, Sanyal AJ, et al. Biochemical and histologic evaluation of recurrent hepatitis C following orthotopic liver transplantation. Transplantation 1994;57:526-532.
27. Gretch DR, Bacchi CE, Corey L, dela Rosa C, Lesniewski RR, Kowdley K, et al. Persistent hepatitis C virus infection after liver transplantation: clinical and virological features. Hepatology 1995;22:1-9.